<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1405-9940</journal-id>
<journal-title><![CDATA[Archivos de cardiología de México]]></journal-title>
<abbrev-journal-title><![CDATA[Arch. Cardiol. Méx.]]></abbrev-journal-title>
<issn>1405-9940</issn>
<publisher>
<publisher-name><![CDATA[Instituto Nacional de Cardiología Ignacio Chávez]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1405-99402016000400367</article-id>
<article-id pub-id-type="doi">10.1016/j.acmx.2016.06.004</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[El SPRINT en la práctica médica: ¿es momento de modificar el manejo de la hipertensión arterial en Latinoamérica?]]></article-title>
<article-title xml:lang="en"><![CDATA[SPRINT on clinical practice: It's time to change the management of arterial hypertension in Latin America?]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Galvez-Olortegui]]></surname>
<given-names><![CDATA[José Kelvin]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="A a"/>
<xref ref-type="aff" rid="A02"/>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="A a"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Condor-Rojas]]></surname>
<given-names><![CDATA[Yudy]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="A a"/>
<xref ref-type="aff" rid="A05"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Galvez-Olortegui]]></surname>
<given-names><![CDATA[Tomas Vladimir]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="A a"/>
<xref ref-type="aff" rid="A06"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Camacho-Saavedra]]></surname>
<given-names><![CDATA[Luis]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="A a"/>
<xref ref-type="aff" rid="A04"/>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Scientia Clinical and Epidemiological Research Institute  ]]></institution>
<addr-line><![CDATA[Trujillo ]]></addr-line>
<country>Perú</country>
</aff>
<aff id="A02">
<institution><![CDATA[,Centro Médico - 32  ]]></institution>
<addr-line><![CDATA[Trujillo ]]></addr-line>
<country>Perú</country>
</aff>
<aff id="A03">
<institution><![CDATA[,aff03  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Escocia</country>
</aff>
<aff id="A04">
<institution><![CDATA[,Universidad Nacional de Trujillo  ]]></institution>
<addr-line><![CDATA[Trujillo ]]></addr-line>
<country>Peru</country>
</aff>
<aff id="A05">
<institution><![CDATA[,Universidad Peruana de Ciencias Aplicadas  ]]></institution>
<addr-line><![CDATA[Lima ]]></addr-line>
<country>Peru</country>
</aff>
<aff id="A06">
<institution><![CDATA[,Universidad Privada Antenor Orrego  ]]></institution>
<addr-line><![CDATA[Trujillo ]]></addr-line>
<country>Peru</country>
</aff>
<aff id="A07">
<institution><![CDATA[,Hospital I «Florencia de Mora»  ]]></institution>
<addr-line><![CDATA[Trujillo ]]></addr-line>
<country>Perú</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2016</year>
</pub-date>
<volume>86</volume>
<numero>4</numero>
<fpage>367</fpage>
<lpage>373</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S1405-99402016000400367&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S1405-99402016000400367&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S1405-99402016000400367&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen El presente documento analiza la factibilidad de la implementación de los resultados del ensayo clínico SPRINT, la necesidad de replantear las guías de práctica clínica (GPC) para el manejo de la hipertensión arterial y los costos asociados a su aplicabilidad en la práctica diaria. El SPRINT es un ensayo clínico que comparó el control intensivo de la presión arterial sistólica &lt;120 mmHg y &lt;140 mmHg sobre las complicaciones cardiovasculares, generando un gran impacto en el mundo seguido de la publicación de diversos estudios que han abordado desde diversas perspectivas la relevancia, utilidad, aplicabilidad y aspectos controversiales del SPRINT. El logro de la presión arterial meta es uno de los temas más discutidos en las GPC de hipertensión arterial de mayor uso a nivel mundial y latinoamericano. El SPRINT ha generado y generará un gran impacto en las GPC, siendo necesaria la reevaluación de las presiones arteriales meta y su inclusión en las GPC futuras, como ha sido considerado por la guía canadiense 2016 y será considerado en la actualización de la Guía NICE programada para junio. El ensayo SPRINT plantea nuevas evidencias para el manejo de la hipertensión arterial, útil en personas mayores de 50 años, procedentes de poblaciones urbanas, con riesgo cardiovascular definido y sin comorbilidades asociadas. La aplicabilidad del SPRINT en Latinoamérica es limitada por el aumento de costos asociados a la atención de salud integral del paciente hipertenso, la baja cobertura de atención y escasez de programas integrales de atención.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract This paper analyzes the feasibility of the implementation of SPRINT trial results, the need to rethink the clinical practice guidelines(CPG) for the management of arterial hypertension and associated costs with daily practice applicability. SPRINT is a clinical trial comparing systolic blood pressure control &lt;120 mmHg and &lt;140 mmHg over cardiovascular complications, generating a great worldwide impact followed by publication of several studies that addressed relevance, usefulness, applicability and controversial aspects of SPRINT from different perspectives. Achieving blood pressure goals is one of the most discussed issue in widely used hypertension CPG around the world and in Latin American. SPRINT has generated and will generate a great impact on CPG, being necessary the reassessment of blood pressure goals and inclusion in future CPG, as has been considered in 2016 Canadian guideline and will be considered in NICE guideline update scheduled for June. The SPRINT trial raises new evidence for the management of hypertension, useful in people over 50 years, from urban populations, with defined cardiovascular risk without associated comorbidities. The applicability of SPRINT in Latin America is limited by increased costs associated with hypertensive patients&#8217; integrated health care, low care coverage, and lack of integrated care programs.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[Hipertensión]]></kwd>
<kwd lng="es"><![CDATA[Presión arterial]]></kwd>
<kwd lng="es"><![CDATA[Guías de práctica clínica]]></kwd>
<kwd lng="es"><![CDATA[Ensayo clínico]]></kwd>
<kwd lng="es"><![CDATA[Perú]]></kwd>
<kwd lng="en"><![CDATA[Hypertension]]></kwd>
<kwd lng="en"><![CDATA[Arterial Pressure]]></kwd>
<kwd lng="en"><![CDATA[Practice guidelines]]></kwd>
<kwd lng="en"><![CDATA[Clinical trial]]></kwd>
<kwd lng="en"><![CDATA[Perú]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Accessing preappraised evidence Fine-tuning the 5 S model into a 6 S model]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dicenso]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bayley]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Haynes]]></surname>
<given-names><![CDATA[RB]]></given-names>
</name>
</person-group>
<source><![CDATA[Ann Intern Med]]></source>
<year>2009</year>
<volume>151</volume>
<page-range>5-6</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="book">
<collab>Institute of Medicine</collab>
<source><![CDATA[Clinical practice guidelines we can trust]]></source>
<year>2011</year>
<publisher-loc><![CDATA[Washington DC ]]></publisher-loc>
<publisher-name><![CDATA[The National Academies Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Improving the use of research evidence in guideline development 2. Priority setting]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Oxman]]></surname>
<given-names><![CDATA[AD]]></given-names>
</name>
<name>
<surname><![CDATA[Schünemann]]></surname>
<given-names><![CDATA[HJ]]></given-names>
</name>
<name>
<surname><![CDATA[Fretheim]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Health Res Policy Syst]]></source>
<year>2006</year>
<volume>4</volume>
<page-range>1-7</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[A Randomized trial of intensive versus standard blood-pressure control]]></article-title>
<collab>The SPRINT Research Group</collab>
<source><![CDATA[NEJM]]></source>
<year>2015</year>
<volume>373</volume>
<page-range>2103-16</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="">
<collab>National Hearth, Lung and BI</collab>
<source><![CDATA[Landmark NIH study shows intensive blood pressure management may save lives]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[El estudio SPRINT en la práctica clínica ¿se debe modificar el objetivo de control de la presión arterial?]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ruilope]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Banegas]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
</person-group>
<source><![CDATA[Hipertens Riesgo Vasc]]></source>
<year>2016</year>
<volume>33</volume>
<page-range>47-50</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The J-curve phenomenon revisited again SPRINT outcomes favor target systolic blood pressure below 120 mmHg]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kjeldsen]]></surname>
<given-names><![CDATA[SE]]></given-names>
</name>
<name>
<surname><![CDATA[Oparil]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Narkiewicz]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<source><![CDATA[Blood Press]]></source>
<year>2016</year>
<volume>25</volume>
<page-range>1-3</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Successes of SPRINT, but still some hurdles to cross]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Touyz]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Dominiczak]]></surname>
<given-names><![CDATA[AF]]></given-names>
</name>
</person-group>
<source><![CDATA[Hypertension]]></source>
<year>2016</year>
<volume>67</volume>
<page-range>268-9</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[SPRINT, or false start, toward a lower universal treated blood pressure target in hypertension]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Esler]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Hypertension]]></source>
<year>2016</year>
<volume>67</volume>
<page-range>266-7</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[SPRINT What remains unanswered and where do we go from here?]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[DW]]></given-names>
</name>
<name>
<surname><![CDATA[Weatherly]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Hall]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
</person-group>
<source><![CDATA[Hypertension]]></source>
<year>2016</year>
<volume>67</volume>
<page-range>261-2</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Effects of blood pressure lowering on outcome incidence in hypertension 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels - updated overview and metaanalyses of randomized trials]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Thomopoulos]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Parati]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Zanchetti]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[J Hypertens]]></source>
<year>2016</year>
<volume>34</volume>
<page-range>613-22</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Generalizability of SPRINT results to the U S. adult population]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bress]]></surname>
<given-names><![CDATA[AP]]></given-names>
</name>
<name>
<surname><![CDATA[Tanner]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Hess]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[J Am Coll Cardiol]]></source>
<year>2016</year>
<volume>67</volume>
<page-range>463-72</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Cardiovascular outcomes according to systolic blood pressure in patients with and without diabetes an ACCOMPLISH substudy]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Weber]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Bloch]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bakris]]></surname>
<given-names><![CDATA[GL]]></given-names>
</name>
</person-group>
<source><![CDATA[J Clin Hypertens]]></source>
<year>2016</year>
<volume>18</volume>
<page-range>299-307</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Continuation of the ESH-CHLSHOT trial after publication of the SPRINT rationale for further study on blood pressure targets of antihypertensive treatment after stroke]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zanchetti]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Mancia]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[J Hypertens]]></source>
<year>2016</year>
<volume>34</volume>
<page-range>393-6</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Effects of intensive blood-pressure control in type 2 diabetes mellitus (ACCORD)]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cushman]]></surname>
<given-names><![CDATA[WC]]></given-names>
</name>
<name>
<surname><![CDATA[Evans]]></surname>
<given-names><![CDATA[GW]]></given-names>
</name>
<name>
<surname><![CDATA[Byington]]></surname>
<given-names><![CDATA[RP]]></given-names>
</name>
</person-group>
<source><![CDATA[NEJM]]></source>
<year>2010</year>
<volume>362</volume>
<page-range>1575-85</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Effects of intensive blood pressure lowering on cardiovascular and renal outcomes updated systematic review and meta-analysis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Xie]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Atkins]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Lv]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Lancet]]></source>
<year>2015</year>
<volume>6736</volume>
<page-range>1-9</page-range></nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[SPRINT Trial Results Latest news in hypertension management]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cushman]]></surname>
<given-names><![CDATA[WC]]></given-names>
</name>
<name>
<surname><![CDATA[Whelton]]></surname>
<given-names><![CDATA[PK]]></given-names>
</name>
<name>
<surname><![CDATA[Fine]]></surname>
<given-names><![CDATA[LJ]]></given-names>
</name>
</person-group>
<source><![CDATA[Hypertension]]></source>
<year>2016</year>
<volume>67</volume>
<page-range>263-5</page-range></nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jamerson]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Weber]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Bakris]]></surname>
<given-names><![CDATA[GL]]></given-names>
</name>
</person-group>
<source><![CDATA[NEJM]]></source>
<year>2008</year>
<volume>359</volume>
<page-range>2417-28</page-range></nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Blood pressure lowering for prevention of cardiovascular disease and death a systematic review and meta-analysis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ettehad]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Emdin]]></surname>
<given-names><![CDATA[CA]]></given-names>
</name>
<name>
<surname><![CDATA[Kiran]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Lancet]]></source>
<year>2016</year>
<volume>387</volume>
<numero>10022</numero>
<issue>10022</issue>
<page-range>957-67</page-range></nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Usefulness for surveillance of hypertension prevalence studies in Latin America and the Caribbean the past 10 years]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Burroughs Peña]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Mendes Abdala]]></surname>
<given-names><![CDATA[CV]]></given-names>
</name>
<name>
<surname><![CDATA[Silva]]></surname>
<given-names><![CDATA[LC]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Panam Salud Publica]]></source>
<year>2012</year>
<volume>32</volume>
<page-range>15-21</page-range></nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chow]]></surname>
<given-names><![CDATA[CK]]></given-names>
</name>
<name>
<surname><![CDATA[Teo]]></surname>
<given-names><![CDATA[KK]]></given-names>
</name>
<name>
<surname><![CDATA[Rangarajan]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[JAMA]]></source>
<year>2013</year>
<volume>310</volume>
<page-range>959-68</page-range></nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Major cardiovascular risk factors in Latin America a comparison with the United States. The Latin American Consortium of Studies in Obesity (LASO)]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Miranda]]></surname>
<given-names><![CDATA[JJ]]></given-names>
</name>
<name>
<surname><![CDATA[Herrera]]></surname>
<given-names><![CDATA[VM]]></given-names>
</name>
<name>
<surname><![CDATA[Chirinos]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<source><![CDATA[PLoS One]]></source>
<year>2013</year>
<volume>8</volume>
<page-range>e54056</page-range></nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[La hipertensión arterial en el Perú según el estudio TORNASOL II]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Segura]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Agustín]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<source><![CDATA[Rev Peru Cardiol]]></source>
<year>2006</year>
<volume>32</volume>
<page-range>82-128</page-range></nlm-citation>
</ref>
<ref id="B24">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Hypertension prevalence, awareness, treatment, and control in selected LMIC communities]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Irazola]]></surname>
<given-names><![CDATA[VE]]></given-names>
</name>
<name>
<surname><![CDATA[Gutierrez]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Bloomfield]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<source><![CDATA[Glob Heart]]></source>
<year>2016</year>
<volume>11</volume>
<page-range>47-59</page-range></nlm-citation>
</ref>
<ref id="B25">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Hypertension in Mexico and among Mexican Americans prevalence and treatment patterns]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Barquera]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Durazo-Arvizu]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Luke]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[J Hum Hypertens]]></source>
<year>2008</year>
<volume>22</volume>
<page-range>617-26</page-range></nlm-citation>
</ref>
<ref id="B26">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[How quickly do systematic reviews go out of date A survival analysis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shojania]]></surname>
<given-names><![CDATA[KG]]></given-names>
</name>
<name>
<surname><![CDATA[Sampson]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ansari]]></surname>
<given-names><![CDATA[MT]]></given-names>
</name>
</person-group>
<source><![CDATA[Ann Intern Med]]></source>
<year>2007</year>
<volume>147</volume>
<page-range>224-33</page-range></nlm-citation>
</ref>
<ref id="B27">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Validity of the agency for healthcare research and quality clinical practice guidelines how quickly do guidelines become outdated?]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Shekelle]]></surname>
<given-names><![CDATA[PG]]></given-names>
</name>
<name>
<surname><![CDATA[Ortiz]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Rhodes]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[JAMA]]></source>
<year>2001</year>
<volume>286</volume>
<page-range>1461-7</page-range></nlm-citation>
</ref>
<ref id="B28">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Clinical practice guidelines in hypertension a review]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alvarez-Vargas]]></surname>
<given-names><![CDATA[ML]]></given-names>
</name>
<name>
<surname><![CDATA[Galvez-Olortegui]]></surname>
<given-names><![CDATA[JK]]></given-names>
</name>
<name>
<surname><![CDATA[Galvez-Olortegui]]></surname>
<given-names><![CDATA[TV]]></given-names>
</name>
</person-group>
<source><![CDATA[Medwave]]></source>
<year>2015</year>
<volume>15</volume>
<page-range>e6290</page-range></nlm-citation>
</ref>
<ref id="B29">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[2014 evidence-based guideline for the management of high blood pressure in adults report from the panel members appointed to the Eighth Joint National Committee (JNC 8)]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[James]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Oparil]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Carter]]></surname>
<given-names><![CDATA[BL]]></given-names>
</name>
</person-group>
<source><![CDATA[JAMA]]></source>
<year>2014</year>
<volume>311</volume>
<page-range>507-20</page-range></nlm-citation>
</ref>
<ref id="B30">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mancia]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Fagard]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Narkiewicz]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<source><![CDATA[Blood Press]]></source>
<year>2014</year>
<volume>23</volume>
<page-range>3-16</page-range></nlm-citation>
</ref>
<ref id="B31">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The 2015 Canadian hypertension education program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Daskalopoulou]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Rabi]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
<name>
<surname><![CDATA[Zarnke]]></surname>
<given-names><![CDATA[KB]]></given-names>
</name>
</person-group>
<source><![CDATA[Can J Cardiol]]></source>
<year>2015</year>
<volume>31</volume>
<page-range>549-68</page-range></nlm-citation>
</ref>
<ref id="B32">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Hypertension Canada's 2016 Canadian hypertension education program guidelines for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Leung]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
<name>
<surname><![CDATA[Nerenberg]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Daskalopoulou]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
</person-group>
<source><![CDATA[Can J Cardiol]]></source>
<year>2016</year>
<volume>32</volume>
<page-range>569-88</page-range></nlm-citation>
</ref>
<ref id="B33">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sforza]]></surname>
<given-names><![CDATA[VF]]></given-names>
</name>
</person-group>
<source><![CDATA[J Hypertens]]></source>
<year>2003</year>
<volume>21</volume>
<page-range>1011-53</page-range></nlm-citation>
</ref>
<ref id="B34">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dasgupta]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Quinn]]></surname>
<given-names><![CDATA[RR]]></given-names>
</name>
<name>
<surname><![CDATA[Zarnke]]></surname>
<given-names><![CDATA[KB]]></given-names>
</name>
</person-group>
<source><![CDATA[Can J Cardiol]]></source>
<year>2014</year>
<volume>30</volume>
<page-range>485-501</page-range></nlm-citation>
</ref>
<ref id="B35">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Seventh report of the Joint National committee on prevention, detection, evaluation, and treatment of high blood pressure]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chobanian]]></surname>
<given-names><![CDATA[AV]]></given-names>
</name>
<name>
<surname><![CDATA[Bakris]]></surname>
<given-names><![CDATA[GL]]></given-names>
</name>
<name>
<surname><![CDATA[Black]]></surname>
<given-names><![CDATA[HR]]></given-names>
</name>
</person-group>
<source><![CDATA[Hypertension]]></source>
<year>2003</year>
<volume>42</volume>
<page-range>1206-52</page-range></nlm-citation>
</ref>
<ref id="B36">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Applicability of the current hypertension guidelines in Latin America]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alcocer]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Meaney]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Hernandez-Hernandez]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<source><![CDATA[Ther Adv Cardiovasc Dis]]></source>
<year>2015</year>
<volume>9</volume>
<page-range>118-26</page-range></nlm-citation>
</ref>
<ref id="B37">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Latin American guidelines on hypertension]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sanchez]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Ayala]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Baglivo]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<source><![CDATA[J Hypertens]]></source>
<year>2009</year>
<volume>27</volume>
<page-range>905-22</page-range></nlm-citation>
</ref>
<ref id="B38">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Consenso latinoamericano de hipertensión en pacientes con diabetes tipo 2 y síndrome metabólico]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[López-Jaramillo]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Sánchez]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Díaz]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<source><![CDATA[Clin Investig Arterioscler]]></source>
<year>2013</year>
<volume>26</volume>
<page-range>85-103</page-range></nlm-citation>
</ref>
<ref id="B39">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Grading strength of recommendations and quality of evidence in clinical guidelines report from an american college of chest physicians task force]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Guyatt]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Gutterman]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Baumann]]></surname>
<given-names><![CDATA[MH]]></given-names>
</name>
</person-group>
<source><![CDATA[Chest]]></source>
<year>2006</year>
<volume>129</volume>
<page-range>174-81</page-range></nlm-citation>
</ref>
<ref id="B40">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Hypertension Guidelines Is it time to reappraise blood pressure thresholds and targets]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Touyz]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Dominiczak]]></surname>
<given-names><![CDATA[AF]]></given-names>
</name>
</person-group>
<source><![CDATA[Hypertension]]></source>
<year>2016</year>
<volume>67</volume>
<page-range>688-9</page-range></nlm-citation>
</ref>
<ref id="B41">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Changes in AGREE II assessment of CHEP Guidelines]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Galvez-Olortegui]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Camacho-Saavedra]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Godoy-Palomino]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Can J Cardiol]]></source>
<year>2016</year>
</nlm-citation>
</ref>
<ref id="B42">
<nlm-citation citation-type="">
<collab>National Institute for Health and Clinical Excellence</collab>
<source><![CDATA[Hypertension in adults: diagnosis and management]]></source>
<year>2011</year>
<publisher-loc><![CDATA[London ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B43">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Epidemiological changes and financial consequences of hypertension in Latin America implications for the health system and patients in Mexico]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Arredondo]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Zuñiga]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Cad Saude Publica]]></source>
<year>2012</year>
<volume>28</volume>
<page-range>497-502</page-range></nlm-citation>
</ref>
<ref id="B44">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[The global cost of nonoptimal blood pressure]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gaziano]]></surname>
<given-names><![CDATA[TA]]></given-names>
</name>
<name>
<surname><![CDATA[Bitton]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Anand]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[J Hypertens]]></source>
<year>2009</year>
<volume>27</volume>
<page-range>1472-7</page-range></nlm-citation>
</ref>
<ref id="B45">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Costo de hipertension arterial en los establecimientos de salud del Perú]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Escobedo-Palza]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Timana-Ruiz]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Sobrevilla-Ricci]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Value Health]]></source>
<year>2015</year>
<volume>18</volume>
<page-range>A829</page-range></nlm-citation>
</ref>
<ref id="B46">
<nlm-citation citation-type="">
<collab>Dirección General de Medicamentos Insumos y Drogas</collab>
<source><![CDATA[Observatorio de productos farmacéuticos]]></source>
<year></year>
<publisher-loc><![CDATA[Perú ]]></publisher-loc>
</nlm-citation>
</ref>
<ref id="B47">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Tratamiento farmacológico de la hipertensión arterial en medicina familiar segunda parte]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ramírez-Villaseñor]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<source><![CDATA[Arch en Med Fam]]></source>
<year>2005</year>
<volume>7</volume>
<page-range>99-107</page-range></nlm-citation>
</ref>
<ref id="B48">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents A meta-analysis]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gupta]]></surname>
<given-names><![CDATA[AK]]></given-names>
</name>
<name>
<surname><![CDATA[Arshad]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Poulter]]></surname>
<given-names><![CDATA[NR]]></given-names>
</name>
</person-group>
<source><![CDATA[Hypertension]]></source>
<year>2010</year>
<volume>55</volume>
<page-range>399-407</page-range></nlm-citation>
</ref>
<ref id="B49">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Affordability of antihypertensive treatment in Mexico]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lemus]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Rivas]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<source><![CDATA[Value Health]]></source>
<year>2013</year>
<volume>16</volume>
<page-range>A705</page-range></nlm-citation>
</ref>
<ref id="B50">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Long-term adherence with cardiovascular drug regimens]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kulkarni]]></surname>
<given-names><![CDATA[SP]]></given-names>
</name>
<name>
<surname><![CDATA[Alexander]]></surname>
<given-names><![CDATA[KP]]></given-names>
</name>
<name>
<surname><![CDATA[Lytle]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<source><![CDATA[Am Heart J]]></source>
<year>2006</year>
<volume>151</volume>
<page-range>185-91</page-range></nlm-citation>
</ref>
<ref id="B51">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Evaluación de costoefectividad de la implementación de monitoreo ambulatorio de presión arterial versus perfil de presión arterial para el diagnóstico de hipertensión en el sistema público chileno]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bittner]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Espinoza]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Montero]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Value Health]]></source>
<year>2015</year>
<volume>18</volume>
<page-range>A859</page-range></nlm-citation>
</ref>
<ref id="B52">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Cost-effectiveness of hypertension therapy according to 2014 guidelines]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moran]]></surname>
<given-names><![CDATA[AE]]></given-names>
</name>
<name>
<surname><![CDATA[Odden]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Thanataveerat]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[NEJM]]></source>
<year>2015</year>
<volume>372</volume>
<page-range>447-55</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
